Results 21 to 30 of about 9,189,306 (207)
International Journal of Hematology-Oncology and Stem Cell Research, 2021 Rosai Dorfman disease is a rare histiocytic disorder of over-production of non-Langerhans histiocytes, which typically manifests with massive lymphadenopathy and sinonasal involvement.
Yi Li +5 more
doaj +1 more source
Skin Health and Disease, 2023 Sinus histiocytosis or Rosai‐Dorfman disease (RDD) is a rare disorder with severe lymphadenopathy and a limited clinical course, the aetiology of which is still controversial. The disease usually affects cervical nodes, with fever, polyclonal gammopathy,
A. Tirado-Sánchez
semanticscholar +1 more source
Immunoglobulin G4-Associated Rosai–Dorfman Disease: Report of 3 Cases
European Journal of Rheumatology, 2023 Rosai–Dorfman disease is characterized by dilated lymph node sinuses filled with lymphocytes, plasma cells, and histiocytes. Many of these histiocytes classically exhibit emperipolesis of lymphocytes and plasma cells.
J. Gallo +5 more
semanticscholar +1 more source
Journal of Cytology, 2020 Context: Rosai–Dorfman disease, also known as Sinus histiocytosis with massive lymphadenopathy, is a benign proliferative disorder of histiocytes. It typically affects lymph nodes; however, extranodal disease is being increasingly reported.
Rallapalli Rajyalakshmi +5 more
doaj +1 more source
Cutaneous Rosai-Dorfman Disease: A Treatment Challenge
Dermatologic Therapy, 2021 Rosai-Dorfman disease (RDD) is a benign histiocytosis that rarely manifests as a purely cutaneous form. Its differential diagnosis and treatment can pose a challenge to both clinicians and pathomorphologists.
Anna Gawdzik +5 more
semanticscholar +1 more source
Diagnosis and treatment of Rosai-Dorfman disease of the spine: a systematic literature review
Systematic Reviews, 2021 Purpose To review and summarize the clinical features, diagnosis, treatment strategies, and prognosis of spinal Rosai-Dorfman disease (RDD). Methods RDD is also termed as sinus histiocytosis with massive lymphadenopathy.
P. Hu +3 more
semanticscholar +1 more source
Human Genomics, 2021 Background Mutations in the SLC29A3 gene, which encodes the nucleoside transporter hENT3, have been implicated in syndromic forms of histiocytosis including H syndrome, pigmented hypertrichosis with insulin-dependent diabetes, Faisalabad histiocytosis ...
H. Chouk +8 more
semanticscholar +1 more source
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease
Haematologica, 2019 Rosai-Dorfman disease is a rare subtype of non-Langerhans cell histiocytosis. With the last major report published in 1990, there is a paucity of contemporary data on this disease.
G. Goyal +13 more
semanticscholar +1 more source
Doença de Rosai-Dorfman cutânea Cutaneous Rosai-Dorfman Disease
Anais Brasileiros de Dermatologia, 2009 Doença de Rosai-Dorfman é uma doença benigna e autolimitada. Tem etiologia desconhecida e foi descrita pela primeira vez por Rosai e Dorfman em 1969. As manifestações clássicas incluem linfadenopatia cervical usualmente acompanhada por febre, leucocitose
Fábio Machado Landim +5 more
doaj +1 more source
Rosai-Dorfman Disease of Bone and Soft Tissue.
Archives of Pathology & Laboratory Medicine, 2021 CONTEXT.— Rosai-Dorfman disease is a rare histiocytic proliferative disorder of unknown pathogenesis that may be diagnostically difficult in extranodal sites.
R. A. García, Edward F Dicarlo
semanticscholar +1 more source